Company Quick10K Filing
First Northern Community Bancorp
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-03-05
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-08
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-03-09
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-03-10
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-10
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-18
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-21
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-05-12 Filed 2011-05-12
10-K 2011-03-21 Filed 2011-03-22
10-Q 2010-11-12 Filed 2010-11-12
10-Q 2010-08-11 Filed 2010-08-12
10-Q 2010-05-14 Filed 2010-05-14
10-K 2010-03-29 Filed 2010-03-29
8-K 2020-05-09
8-K 2020-04-29
8-K 2020-01-28
8-K 2019-12-31
8-K 2019-09-30
8-K 2019-06-30
8-K 2019-05-17
8-K 2019-03-31
8-K 2018-12-31
8-K 2018-09-30
8-K 2018-06-30
8-K 2018-06-21
8-K 2018-05-17
8-K 2018-03-31
8-K 2018-01-16
8-K 2017-12-31

First Northern Community Bancorp Financials

FNRN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cytodyn (CYDY) 171 -3.5 -269% 21 30 0 0 -56 -49 172
Northwest Biotherapeutics (NWBO) 146 0% -6.4 -266% 10 65 2 0 -27 -25 157
Kentucky Bancshares (KTYB) 142 6.7 1% 1,083 966 0 0 10 17 117
Windtree Therapeutics (WINT) 139 0% -5.8 -24% 101 48 0 0 -24 -23 134
SolarWindow Technologies (WNDW) 158 -31.5 -25% 19 0 0 0 -5 -4 140
Mohawk Group (MWK) 136 41% -7.6 -26% 73 53 71 29 -19 -17 127
First Northern Community Bancorp (FNRN) 136 0.0 1% 1,287 1,158 0 0 11 17 0
JRSIS Health Care (JRSS) 135 0% 23.1 5% 54 30 23 0 3 6 133
magicJack VocalTec (CALL) 135 64% 5.6 5% 144 95 80 52 6 13 73
Federal Street Acquisition (FSAC) 135 -26.8 -1% 471 26 0 0 -4 -5 132
Invesco DB Precious Metals Fund (DBP) 133 10.1 10% 134 3 0 0 13 13 133
Bright Mountain Media (BMTM) 133 27% -40.9 -12% 28 7 4 1 -3 -3 132
Living 3D (LTDH) 131 -27% -587.9 -294% 0 1 0 -0 -0 -0 131
Darkpulse (KLMK) 131 -596.4 -114% 1 3 0 0 -1 -0 132
Invesco CurrencyShares Canadian Dollar Trust (FXC) 129 0% -23.9 1% 116 0 2 0 1 1 -24
Gastar Exploration (GST) 129 0% -45.1 -24% 335 448 83 0 -82 -11 485
Contango Ore (CTGO) 129 -16.5 -96% 8 0 0 0 -7 -7 121
Emmaus Life Sciences (EMMA) 128 96% -5.7 -66% 71 95 13 12 -47 -29 165
RenovaCare (RCAR) 127 -51.9 -16% 14 0 0 0 -2 -2 113
WMIH (WMIH) 126 0% -1.9 -2% 18,478 16,711 1,519 0 -325 267 -516

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash133149140143118129161166142150177222207247229254226261201156144159160163132150153149121140116128124136
Accounts Receivable
Inventory
PP&E88888822888227772277722777226662166622666
Assets7477677817947858068318538458768989339319549589951,0021,0381,0451,0561,0701,1191,1671,1671,1571,1931,2181,2041,1871,2441,2501,2191,2321,287
Accounts Payable
Long-Term Debt0000
Liabilities6656786937046957147397697627928138468428648669019079419599689791,0271,0741,0721,0601,0921,1181,1031,0831,1371,1371,1011,1071,158
Stockholders' Equity82888889909292838284858789909294959786889192929598101100101104107112118125130
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax001001011111111111111112222111211
Net Income110111112111122222222223331333434
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating0532192734233-1735-1443544346344
Cash Investing-2-28-11-16-8-2-18-24-2438-1315-11-270-69-54-27-35-501-17-254-10-4147-13-38
Cash Financing181411-10182521-8292035-52137533411114747-33224-12-2153-38646